HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Polycystic ovary syndrome: possible involvement of androgen-induced, chemerin-mediated ovarian recruitment of monocytes/macrophages.

Abstract
Polycystic ovary syndrome (PCOS) is a continuum of endocrine and reproductive disorders characterized by hyperandrogenism, antral follicle growth arrest, and chronic inflammation. Macrophages play key role in inflammation, and the balance between M1 (inflammatory) and M2 (anti-inflammatory) macrophages determines physiological/pathological outcomes. Here, we investigated if hyperandrogenism increases ovarian chemerin altering the balance of M1 and M2 macrophages and the granulosa cell death. Ovarian chemerin was upregulated by 5α-dihydrotestosterone (DHT) in lean and overweight rats; while increased serum chemerin levels were only evident in overweight rats, suggesting that the serum chemerin may be reflective of a systemic response and associated with obesity, whereas increased ovarian chemerin expression is a localized response independent of the metabolic status. DHT altered follicle dynamics while increased the M1: M2 macrophages ratio in antral and pre-ovulatory follicles. While ovarian M1 macrophages expressing chemokine-like receptor 1 (CMKLR1) were increased, CMKLR1+ monocytes, which migrated toward chemerin-rich environment, were markedly decreased after 15 days of DHT. Androgen-induced granulosa cell apoptosis was dependent on the presence of macrophages. In humans, chemerin levels in follicular fluid, but not in serum, were higher in lean PCOS patients compared to BMI-matched controls and were associated with increased M1: M2 ratio. Our results support the concept that in PCOS, hyperandrogenemia increases chemerin expression while promotes CMKLR1+ monocytes recruitment and deregulates the immunological niche of ovaries. This study established a new immunological perspective in PCOS at the ovarian level. Hyperandrogenism is associated with upregulation of chemerin and macrophage unbalance in the ovaries.
AuthorsPatricia D A Lima, Anne-Laure Nivet, Qi Wang, Yi-An Chen, Arthur Leader, Annie Cheung, Chii-Ruey Tzeng, Benjamin K Tsang
JournalBiology of reproduction (Biol Reprod) Vol. 99 Issue 4 Pg. 838-852 (10 01 2018) ISSN: 1529-7268 [Electronic] United States
PMID29688269 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Androgens
  • Chemokines
  • Cmklr1 protein, rat
  • Intercellular Signaling Peptides and Proteins
  • RARRES2 protein, human
  • Rarres2 protein, rat
  • Receptors, Chemokine
  • Dihydrotestosterone
Topics
  • Androgens (metabolism)
  • Animals
  • Apoptosis
  • Cell Movement (physiology)
  • Chemokines (metabolism)
  • Dihydrotestosterone (administration & dosage)
  • Disease Models, Animal
  • Female
  • Granulosa Cells (metabolism, pathology)
  • Humans
  • Hyperandrogenism (metabolism, pathology)
  • Intercellular Signaling Peptides and Proteins (metabolism)
  • Macrophages (classification, metabolism, pathology)
  • Monocytes (metabolism, pathology)
  • Ovary (drug effects, metabolism, pathology)
  • Polycystic Ovary Syndrome (metabolism, pathology)
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Chemokine (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: